Bovine Papillomaviruses — Taxonomy and Genetic Features by Lunardi, Michele et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 5
Bovine Papillomaviruses — Taxonomy and Genetic
Features
Michele Lunardi, Amauri Alcindo Alfieri,
Rodrigo Alejandro Arellano Otonel and
Alice Fernandes Alfieri
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/56195
1. Introduction
Papillomaviruses (PVs) are epitheliotropic viruses that cause benign proliferative lesions in
the skin (warts or papillomas) and mucous membranes (condylomas) of their natural hosts.
However, certain malignant epithelial lesions have been attributed to PVs, especially in cases
of cervical cancer and other human urogenital tract tumors [1].
The first DNA oncovirus recognized was also the first animal PV to be identified. Known as
CRPV (cottontail rabbit papillomavirus), this virus was identified in the 1930s in warts on the
skin of cottontail rabbits [2].
PVs  are  small,  non-enveloped,  icosahedral  viruses  that  replicate  in  the  nuclei  of  squa‐
mous epithelial cells. The diameter of the viral particles varies between 52 and 55 nm (Figure
1) [1].
Currently, PVs constitute a widely diverse group of DNA viruses. PVs have been found in
many mammal species, as well as in certain birds and reptiles. In addition to human beings
(human  papillomavirus  –  HPV),  PVs  have  been  identified  in  most  domestic  animals,
including bovines (BPV),  canines  (CPVs),  goats  (Capra hircus papillomavirus –  ChPV1),
equines (Equus caballus papillomavirus EcPVs), domestic felines (Felis domesticus papilloma‐
virus – FdPV), sheep (Ovis aries papillomavirus – OaPV), and swine (Sus scrofa papilloma‐
virus – SsPV1) [3].
© 2013 Lunardi et al.; licensee InTech. This is a paper distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
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2. Taxonomic classification of PVs
Originally, PVs were grouped with the polyomaviruses in the family Papovaviridae, which
was justified based on such shared traits as morphologically similar non-enveloped cap‐
sids  and circular  double-stranded DNA genomes.  Because  the  genomes  of  both  groups
were later found to exhibit  different sizes and organizations,  as well  as a low similarity
between their  nucleotide (nt)  and aminoacid (aa)  sequences,  PVs are currently classified
in the family Papillomaviridae [4,5].
PVs are  traditionally  designated as  “viral  types”.  Each viral  type represents  a  complete
genome with the L1 gene nt sequence – which encodes the main capsid protein – exhibit‐
ing at least 10% dissimilarity compared with the same sequence from any other previous‐
ly identified PV [5].
The classification of PVs into genera unites several phylogenetically related species that differ
with respect to their biological properties, whereas classification based on species groups
phylogenetically close viral types that also exhibit similar biological and pathological traits. In
terms of nt sequence identity, these taxonomic relationships are expressed as follows: i)
different genera exhibit less than 60% similarity in their L1 ORFs (open reading frames) and
less than 23% to 43% when their full genomic sequences are compared; ii) different species
within the same genus exhibit 60% to 70% similarity in their L1 ORFs (Table 1) [5].
Currently, the family Papillomaviridae contains at least 29 genera that include more than 200
PV types. The Greek alphabet is used to name the genera, which thus range from Alphapapil‐
lomavirus to Dyoiotapapillomavirus. Each species is designated according to the viral type that
Figure 1. Electron micrograph of bovine papillomavirus type 1 virions (BPV1) (diameter of 55 nm). Source: [1].
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best represents it, whereas the remaining PV types classified within a single species are named
as virus strains (Table 2).
Genera Species
Alphapapillomavirus Human Papillomavirus 2, 6, 7, 10, 16, 18, 26, 32, 34, 53, 54, 61, 90Macaca mulata Papillomavirus 1
Betapapillomavirus Human Papillomavirus 5, 9, 49, 92, 96Macaca fascicularis Papillomavirus 2
Gammapapillomavirus Human Papillomavirus 4, 48, 50, 60, 88, 101, 109, 112, 116, 121
Deltapapillomavirus
Alces alces Papillomavirus 1
Bos taurus Papillomavirus1
Capreolus capreolus Papillomavirus 1
Odocoileus virginianus Papillomavirus1
Ovis aries Papillomavirus 1
Epsilonpapillomavirus Bos taurus Papillomavirus 5
Zetapapillomavirus Equus caballus Papillomavirus 1
Etapapillomavirus Fringilla coelebs Papillomavirus
Thetapapillomavirus Psittacus erithacus Papillomavirus 1
Iotapapillomavirus Mastomys natalensis Papillomavirus 1
Kappapapillomavirus Oryctolagus cuniculus Papillomavirus 1Sylvilagus floridanus Papillomavirus 1
Lambdapapillomavirus
Canis familiaris Papillomavirus 1 and 6
Felis domesticus Papillomavirus 1
Procyon lotor Papillomavirus 1
Mupapillomavirus Human Papillomavirus 1 and 63
Nupapillomavirus Human papillomavirus 41
Xipapillomavirus Bos taurus Papillomavirus 3
Pipapillomavirus Mesocricetus auratus Papillomavirus 1Micromys minutus Papillomavirus 1
Rhopapillomavirus Trichechus manatus latirostris Papillomavirus 1
Taxonomic Level L1 ORF Identity
Genus <60%
Species 60-70%
Viral Type 71-89%
Table 1. Relationship between diverse taxonomic levels and the identity observed on the L1 ORF nt sequences.
Source: [5].
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Genera Species
Sigmapapillomavirus Erethizon dorsatum Papillomavirus 1
Taupapillomavirus Canis familiaris Papillomavirus 2
Upsilonpapillomavirus Tursiops truncatus Papillomavirus 1 and 2
Phipapillomavirus Capra hircus Papillomavirus 1
Chipapillomavirus Canis familiaris Papillomavirus 3 and 4
Psipapillomavirus Rousettus aegyptiacus Papillomavirus 1
Omegapapillomavirus Ursus maritimus Papillomavirus 1
Dyodeltapapillomavirus Sus scrofa Papillomavirus 1
Dyoepsilonpapillomavirus Francolinus leucoscepus Papillomavirus 1
Dyozetapapillomavirus Caretta caretta Papillomavirus 1
Dyoetapapillomavirus Erinaceus europaeus Papillomavirus 1
Dyothetapapillomavirus Felis domesticus Papillomavirus 2
Dyoiotapapillomavirus Equus caballus Papillomavirus 2
Table 2. Classification of Papillomaviridae family. Source: [3].
PVs isolated from vertebrates are classified into 24 genera, whereas viral species that occur
exclusively in birds and reptiles are grouped into three genera and one genus, respectively.
The taxonomic nomenclature of animal PV types is based on the scientific name of their hosts
according to the genus and species. For example, FdPV1 is the name given to PV of the domestic
cat (Felis domesticus) type 1 [3]. An exception occurs in the case of the bovine papillomavirus,
which was named Bos taurus papillomavirus but by consensus is usually referred to as BPV.
Table 3 describes the genera and species of PVs identified in various species of domestic
animals.
Because PVs are not amenable to isolation using classic cell culture techniques and do not
induce a strong humoral immune response in their hosts, the taxonomic terms “strain” and
“serotype” were not originally applied to this virus family. Consequently, the family classifi‐
cation is based on the similarities between nt sequences and a limited number of biological
and medical properties [5,6].
3. Genomic organization
In the 1970s, the cloning of PVs genomes contributed substantially to the study of their
biological and biochemical properties. Sequencing of the cloned genomes allowed the
identification of different ORFs as probable viral genes [7].
The genomic organization of the various PVs is notably similar. A common feature of PVs is
that all of the ORFs are contained on a single strand of the viral DNA. Therefore, only one of
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the DNA strands serves as a template for transcription. The coding strand might exhibit up to
10 ORFs, which are classified according to the cell differentiation stage when they are ex‐
pressed by means of the letters E (early) and L (late). The early genomic segment (E) comprises
up to eight ORFs, which are expressed in epithelial cells in the early stages of maturation.The
Genera Species Viral Strains
Deltapapillomavirus
Bos taurus Papillomavirus 1
Bos taurus Papillomavirus 1
Bos taurus Papillomavirus 2
Ovis aries Papillomavirus 1
Ovis aries Papillomavirus 1
Ovis aries Papillomavirus 2
Epsilonpapillomavirus Bos taurus Papillomavirus 5
Bos taurus Papillomavirus 5
Bos taurus Papillomavirus 8
Zetapapillomavirus Equus caballus Papillomavirus 1 Equus caballus Papillomavirus 1
Lambdapapilloamvirus
Canis familiaris Papillomavirus 1 Canis familiaris Papillomavirus 1
Canis familiaris Papillomavirus 6 Canis familiaris Papillomavirus 6
Felis domesticus Papillomavirus 1 Felis domesticus Papillomavirus 1
Xipapillomavirus Bos taurus Papillomavirus 3
Bos taurus Papillomavirus 3
Bos taurus Papillomavirus 4
Bos taurus Papillomavirus 6
Bos taurus Papillomavirus 9
Bos taurus Papillomavirus 10
Bos taurus Papillomavirus 11
Bos taurus Papillomavirus 12
Taupapillomavirus Canis familiaris Papillomavirus 2
Canis familiaris Papillomavirus 2
Canis familiaris Papillomavirus 7
Phipapillomavirus Capra hircus Papillomavirus 1 Capra hircus Papillomavirus 1
Chipapillomavirus
Canis familiaris Papillomavirus 3
Canis familiaris Papillomavirus 3
Canis familiaris Papillomavirus 5
Canis familiaris Papillomavirus 4 Canis familiaris Papillomavirus 4
Dyodeltapapillomavirus Sus scrofa Papillomavirus 1 Sus scrofa Papillomavirus 1
Dyothetapapillomavirus Felis domesticus Papillomavirus 2 Felis domesticus Papillomavirus 2
Dyoiotapapillomavirus Equus caballus Papillomavirus 2 Equus caballus Papillomavirus 2
- - Bos taurus Papillomavirus 7
Table 3. Papillomavirus species that infect domestic animals. Source: Adapted from [3].
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late segment (L) usually contains two ORFs that are expressed in differentiated keratinocytes.
A third region without ORFs has been identified in all PV genomes and is named the LCR
(long control region) or URR (upstream regulatory region).This region contains the origin of
replication and elements that control transcription (Figure 2) [1].
Figure 2. Schematic representation of genome of bovine papillomavirus type 1 (BPV1).
Expression of the six most common non-structural and regulatory proteins (E1, E2, E4, E5, E6,
and E7), which are encoded by the early viral genome region, occurs in basal cells or during
the intermediate stages of maturation. The expression of the two viral structural proteins (L1
and L2) encoded by the late genomic segment occurs in keratinocytes in the final stage of
maturation [8].
4. Viral proteins
4.1. Proteins E1 and E2
Protein E1 is encoded by the largest ORF found in the early genomic segment of PVs. Significant
homology among the different PVs has been found upon comparison of the amino acid
sequences inferred for the proteins that are encoded by the E1 gene [9].
Together with viral protein E2, protein E1 recognizes the origin of replication and represents
the central factor of PV replication. It is indispensable for the initiation of viral DNA replication.
In addition to this main function, E1 participates in the recruitment of host cell replication
proteins and exhibits intrinsic ATPase/helicase activity, which induces relaxation of the DNA
coiling at the origin of replication and during the progression of the replication fork [9].
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Transformation studies using BPV1 have shown that the presence of an intact E1 ORF is crucial
for the maintenance of viral genome stability in cells through the presence of multiple genomic
copies in episomal form [10,11,12].
However, the interaction between protein E1 and the origin of replication exhibits low
specificity. Specific and efficient recognition of the origin of replication occurs exclusively
through the cooperative binding of proteins E1 and E2 to sites adjacent to the origin of
replication. Therefore, protein E2 participates in this mechanism as an aggregation factor that
promotes the recruitment of helicase E1 to the origin of replication [13].
The BPV1 E2 ORF encodes a protein that comprise the central viral regulatory system and thus
control genetic expression and viral replication. Protein E2 also modulates the transcription of
the early viral promoters through its binding sites [14]. In addition, E2 participates in the
maintenance of the viral genome in its episomal form by promoting binding between these
genomes and mitotic chromosomes during cell division [15,16].
4.2. Protein E4
The non-structural protein E4 occurs abundantly in the cytoplasm of the differentiated
keratinocytes of papillomas. Therefore, although the gene that encodes this protein is located
in the early viral genome region, E4 is produced later in the differentiation process. The E4
protein of HPV16 has also been associated with the collapse of cytokeratin filaments, which
thus suggests an auxiliary function in the process of viral exit from cells [1].
4.3. Proteins E5, E6 and E7
In humans, the oncoproteins E5, E6, and E7 encoded by the genomes of certain HPVs, represent
the primary viral factors related to the onset and progression of cervical cancer. These genetic
products are able to override the negative regulation of cell growth that is mediated by host
cell proteins. In addition, it is believed that these viral oncoproteins promote the genomic
instability observed in HPV-related cancers [17].
Binding with proteins of the retinoblastoma family is the main mechanism by which protein
E7 contributes to the escape of infected cells from the negative regulatory mechanisms of cell
growth. In the case of HPV, protein E7 interacts with these cellular factors and targets them
for degradation [18]. The result of such binding and degradation is the release and activation
of E2F transcription factors that regulate the expression of genes during S phase of the cell
cycle. Efficient interaction between E7 and these factors triggers a compensatory inhibition of
cell growth and apoptosis that is mediated by the p53 tumor suppressor protein-dependent
pathway [17].
The targeting of protein p53 for degradation by viral protein E6 in high-risk HPVs eliminates
the inhibition of cell growth in both undifferentiated and differentiated cells [17]. The actions
of the viral proteins E6 and E7 to abrogate these regulatory factors of the cell cycle allow
infected cells undergoing differentiation to remain in S phase. As a result, many cell cycle
checkpoints are abrogated. Consequently, an accumulation of mutations and progression into
cancer occurs in cells that are persistently infected by these viruses [19].
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Most of the tumors of cattle affected by enzootic hematuria express the BPV2 oncoprotein E5
[20,21,22]. The onset of cellular transformation that is triggered by E5 might occur mainly
through its interaction with and activation of the platelet-derived growth factor (PDGF) β
receptor. Thus, a mitogenic response is induced even in the absence of PDGF [23,24].
4.4. Proteins L1 and L2
The viral capsid consists of the two structural proteins L1 (ca. 55 kDa) and L2 (ca. 70 kDa), being
L1 the major capsid protein and representing approximately 80% of the total virus protein [25].
Virus-like particles (VLPs) can be produced using prokaryotic and eukaryotic systems to
express combination of L1 and L2 or L1 alone [26,27]. Although L2 is not needed for viral
assembly, it is incorporated in the VLPs when it is co-expressed with L1. Under cryoelectron
microscopy, the morphology of the VLPs that contain only L1 appear identical to that of intact
viral particles (Figure 3) [28]. The epitopes that induce the production of neutralizing anti‐
bodies are principally found on L1 but might also be present on L2 (Table 4) [29].
Figure 3. Electron micrograph of VLP sproduced through expression of BPV2 L1.
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Viral Proteins Approximate size(kDa) Function / activity
E1 68.1 recognition of origin of replication / helicase activity
E2 34.3 recruitment of E1 to the origin of replication / modulation of thetranscription of the early viral promoters
E4 12.5 presumed auxiliary function in the virion exit from infected cells
E5 5.2 interacts with and activates the platelet-derived growth factor (PDGF) βreceptor
E6 15.8 targets p53 tumor suppressor protein
E7 13.6 binds to proteins of the retinoblastoma family
L1 55.5 component of the viral capsid
L2 50.5 component of the viral capsid
Table 4. Viral proteins and their functions.
5. Clinical conditions in cattle
Infections by different BPV types are related to several clinical conditions in cattle. The
occurrence of the benign skin tumors that characterize cutaneous papillomatosis might be
found in several areas of the animals’ bodies. Depending on the extent of lesions, the devel‐
opment of the animals might be affected, they might become predisposed to secondary
infections and/or infestations, and their hidescan be damaged. These possibilities are a few of
the potential consequences that might result in economic losses for the beef and, even more
so, dairy industries. Papillomas affecting the udders and teats of lactating cows cause diffi‐
culties with feeding calves and manual and mechanical milking, whereas secondary bacterial
infections predispose the animals to clinical and/or subclinical ascending mastitis [30].
The interaction between specific BPV types and prolonged bracken (Pteridium aquilinum)
intake has been suggested as the cause of enzootic hematuria and upper gastrointestinal tract
cancers in cattle. With regard to enzootic hematuria, it is believed that latent or subclinical
infections with BPV1 or BPV2 occur first in the bladder mucosa. Because the bladder represents
the main target of bracken toxins, once the virus is established, infection might be reactivated,
which might induce neoplasia through the immunosuppressant and carcinogenic chemical
compounds present in bracken, which results in progression to malignancy [31].
Although the incidence of such tumors varies among cattle raised on bracken-infested
pastures, it might be higher than 90% among adult animals [31,32].
With regard to gastrointestinal tract tumors, the immunosuppression associated with bracken
intake is defining for the persistence of BPV4-induced papillomas, which might progress into
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malignant carcinomas under the influence of the carcinogenic elements present in bracken
[33,34,35].
Therefore, although infection by these BPVs plays a central role in the pathogenesis of these
cattle neoplasias, the presence of environmental and biological cofactors is essential for the
development of such lesions [22,36].
6. Diversity of BPVs
Although the genomic sequences of approximately 150 HPV types have already been charac‐
terized, at the beginning of the 1980s only six BPV types (BPV1 to 6) had been identified from
cases of bovine cutaneous papillomatosis and cancer [37-42].
Studies performed from the beginning of  the 2000s onward to investigate the actual  di‐
versity of BPVs have indicated the existence of many BPV types, which is similar to ob‐
servations made regarding the human virus.  The first  such study employed the generic
primer pair FAP59/FAP64 on swabs of healthy skin from 19 species of vertebrates. In six
of the 10 analyzed bovines that did not exhibit any clinical sign compatible with BPV in‐
fection,  one  or  two  putative  new  BPV  types  were  detected.  These  putative  new  viral
types were named BAA1 through BAA5 [43].
Subsequently, a study aimed at establishing the prevalence of BPV in teat papillomas and teat
healthy skin used the primer pairs FAP59/FAP64 and MY09/MY11 to analyze 15 teat papillo‐
mas and 122 swabs of teat healthy skin on cattle from five Japanese prefectures [44]. That study
found four previously characterized BPV types (BPV1, 3, 5, and 6), two of the previously
identified putative new BPV types (BAA1 and 5), and 11 additional putative new types (named
BAPV1 through 10 and BAPV11MY) among the 39 BPV-positive samples. Nevertheless, the
putative new types BAA1 and BAPV7 through 10 were detected only in samples of healthy
skin. In addition, during one outbreak of mammary papillomatosis that occurred in Japan and
affected 560 heifers, the presence of BPV6 was confirmed in the majority of the 16 analyzed
samples [45]. The previously described putative new types BAA5 and BAPV1 were also
identified in these animals.
Although cutaneous papillomatosis poses a serious sanitary problem in beef and, even more
so, dairy cattle, studies aimed at identifying the BPV types involved in the occurrence of skin
lesions in Brazilian cattle are only sporadically performed. Recently, the detection of BPV1, 2,
6, and 8 in papillomas of cattle from the state of Parana was accomplished using generic FAP
primers [46,47]. In another study, the identification of four previously undescribed putative
new BPV types, named BPV/BR-UEL 2 through 5, pointed to the occurrence of considerable
viral diversity among Brazilian cattle [48]. The genetic characterization of one of these new
BPV types, namely, BPV/BR-UEL2, through sequencing of the full L1 gene, confirmed that it
belongs to the genus Xipapillomavirus [49] (Figure 4).
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Figure 4. Phylogenetic reconstruction based on L1 ORF partial nucleotide sequences (FAP amplicons) demonstrating
the classification suggested for the putative new BPV types into the genera Deltapapillomavirus (δ), Epsilonpapilloma‐
virus (ε), Xipapillomavirus (ξ), and a yet unnamed genus that includes BPV7. The numbers at the internal nodes repre‐
sent the bootstrap support values determined for 1000 replicates. The BPV/BR-UEL2, 3, 4, and 5 types are indicated by
shading. Source: [48].
7. New BPV types
Recently, complementary analysis of several putative new BPV types through sequencing of
the full viral genomes allowed the characterization of these new viral types [3]. The first such
new type to be characterized was BPV7, which was initially named BAPV6. Because the nt
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sequence of the BPV7 L1 ORF is more closely related to PVs of the genera Betapapillomavirus,
Gammapapillomavirus, and Pipapillomavirus, which include viruses causing skin lesions in
human beings and the mucosa of hamsters, this new BPV type constitutes a new and yet
unnamed genus [50].
The second recently described BPV type is BPV8, formerly known as BAPV2, which was
identified in Japan. The description of this new viral type was performed together with the
description of a variant named BPV8-EB, which was detected in a case of cutaneous papillo‐
matosis in a European bison born in Italy [51]. The high degree of similarity observed between
the L1 ORF sequences of BPV8 and BPV5 (75%), as well as the results of the phylogenetic
analysis, were the basis for classifying this new viral type in the genus Epsilonpapillomavirus.
In addition, the genomic structures of the early and late regions of these two different members
of the genus were almost identical. The only difference exhibited between them was in the E4
ORF, which is present in BPV8 but absent in BPV5.
Recently, two BPV types, namely, BPV9 and 10, were identified from teat papillomas [52].
These new viral types were initially designated BAPV1 and BAA5 [43,44]. Phylogenetic
analysis and the greater similarity of the L1 ORFs with BPV3 (74.2% and 71.2%, respectively)
allowed the classification of these two new isolates in the genus Xipapillomavirus [52].
Hatama [53] assessed the viral genotypes present in 167 skin warts in Japanese herds through
polymerase chain reaction (PCR), cloning, and sequencing. A total of 124 of the assessed lesions
tested positive for BPV using PCR. Three putative new BPV types, and eight previously
described BPV types (BPV1, 2, 3, 4, 5, 6, 9, and 10) were identified in the partial sequences
obtained from sequencing the PCR products. The characterization of the full sequence of one
of the new BPV types (BPV11) and the comparison of its L1 gene nt sequence to other members
of this viral family allowed its classification in the genus Xipapillomavirus [53].
The complete genome sequence of an isolate identified from an epithelial tongue lesion in a
Japanese bovine was recently obtained, and this isolate was named BPV12 [54]. Comparison
of the BPV12 L1 gene nt sequence to other viral types isolated from cattle suggested that it
should also be classified in the genus Xipapillomavirus.
Recently, the sequencing of the complete genome of the putative new viral type BPV-BR-UEL4,
which was isolated from a skin papilloma on a cow from a herd in southern Brazil,was
performed by subjecting the viral genome to rolling circle amplification (RCA), PCR, the
subsequent cloning of two long amplicons, and sequencing by means of primer walking.
Phylogenetic analysis based on the L1 ORF nt sequences of 45 PVs distributed among 17
genera, including the previously sequenced BPV types and PVs identified from different
artiodactyl species, showed that the new viral type, named BPV13, belongs to the genus
Deltapapillomavirus, which is generally dominated by artiodactyl PVs and also includes BPV1
and 2 (Figure 5). As previously reported for BPV1 and 2, the putative E7 protein of BPV13 does
not contain a retinoblastoma tumor suppressor-binding domain. Additionally, the BPV13 E5
ORF also encodes a small transforming protein (Figure 6) [55]. The combination of these two
different biological aspects has been recognized as a distinct marker for fibropapilloma
development. This pathogenic mechanism appears to be unique among delta-PVs [56].
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Figure 5. Phylogenetic tree based on L1 ORF nt sequences. In addition to 14 genera where animal PVs are classified,
the genera Deltapapillomavirus, Epsilonpapillomavirus, and Xipapillomavirus, which contain BPVs, are indicated in the
tree. Additionally, the six species classified within the Deltapapillomavirus genus are shown. The numbers at the inter‐
nal nodes represent the bootstrap support values determined in 1000 replications. Source: [55]
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Figure 6. A diagram of the genomic organisation of BPV13. The three main regions characteristic of PV genomes are
shown as grey rectangles above the ruler. The viral genome is represented as linear, and ORFs are shown as white
rectangles. The numbers below each ORF indicate the nt positions of the start to stop codons and the corresponding
molecular mass (in parentheses) for each putative viral protein. Source: [55].
8. Co-infections and heterologous infections
In Brazil, the association between BPV infection and the occurrence of cutaneous papilloma‐
tosis, enzootic hematuria, and upper gastrointestinal neoplasias has been confirmed in cattle
[46,48,57-59]. Previous studies have found BPV in tissues other than the skin epithelium. Thus,
BPV1, 2, and 4 have been identified in the embryos and female reproductive tissues of infected
cows [60-63]. Similarly, BPV DNA has been detected in samples of blood, milk, urine, seminal
fluid, and spermatozoa from infected cattle. These findings point to the possible participation
of these fluids and cell types in BPV transmission [64].
In addition, other studies have shown the occurrence of multiple infections in cattle exhibiting
several cutaneous papillomas that are caused by different BPV types and the possibility of
viral co-infections in single lesions [65-68]. Additionally, the presence of several BPV types in
single lesions is similar to the situation in human skin, where co-infection by more than 10
viral types is frequently detected [69].
Each papillomavirus is known to exhibit specificity for a single animal host species in which
it replicates productively. However, only a few viral types are also able to infect a second
animal species. In such cases, non-productive infections, that is, infections without the
production of infective virions, are the result [1]. This type of infection is the case for the equine
sarcoid, which can be defined as a fibroblastic locally invasive skin tumor. Sarcoid is the most
frequent neoplasia affecting equine species, and it represents the best-known example of
heterologous PV infection because it is caused by BPV1 and 2 [70]. In addition to horses,
donkeys, and mules, skin lesions caused by these viral types have also been described in zebras
and buffaloes [71,72]. Another example of heterologous PV infection is provided by the
detection of DNA from FeSarPV (feline sarcoid-associated papillomavirus), a putative new PV
type that was initially identified in feline sarcoids with non-productive infections, in fibropa‐
pillomas and skin samples from cattle with dermatitis [73-75]. The recent detection of FeSarPV
in biological samples from cattle strengthens the hypothesis that cattle might be the natural
host of this virus [73].
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9. Vaccines against BPV
Immunity against BPV is considered to be type-specific, and the immune status of the in‐
fected animals is considered to be the crucial factor for clinical progression. Whereas hu‐
moral  immunity  prevents  new  infections,  cellular  immunity  (possibly  mediated  by  T
lymphocytes) is associated with the spontaneous and immune-mediated regression of es‐
tablished lesions [76].
The finding that epitopes that induce the production of neutralizing antibodies are present in
the structural proteins L1 and L2 explains the success of the use of these proteins in the
production of vaccines [34].
The recent availability of VLP-based immunogens against HPV that are able to protect mainly
against infection by HPV16 and 18 has allowed the development of the first vaccine against
one of the main human neoplasias, i.e., cervical cancer [77]. The data that have been collected
since the implementation of the HPV vaccine are quite encouraging, and these vaccines seem
to be highly efficient [78,79].
In addition, preventive vaccines have been developed for cattle that are mainly against BPV2
and 4. These viral types were selected because they represent the cutaneous and mucous BPVs,
respectively, and are associated with the development of cancer in cattle [80]. A vaccine
prepared with the BPV2 L1 capsid protein produced as a beta-galactosidase fusion protein in
Escherichia coli induced the production of neutralizing antibodies and was able to prevent
infection [81]. A similar effect was achieved using an E. coli derived BVP1 L1 protein, which
protected calves against post-vaccine challenge with a homologous virus [82].
VLPs produced from the L1 or L1 and L2 genes from BPV4 have also proven to be highly
immunogenic and produce powerful prophylactic vaccines. The prevention of infection
during challenge with BPV4 through vaccination with L1 VLPs has shown that L1 promotes
the production of neutralizing antibodies [34]. Vaccination with VLPs produced from BPV4
L1 and L2 proteins in insect cells also efficiently prevented the development of experimentally
induced papillomas [83].
Because BPV does not grow in conventional cell cultures for the production of killed or
attenuated live vaccines, protein expression systems, such as yeast and insect cells, have been
used to produce VLP vaccines. However, the use of these systems is expensive. Recently, as
has been described for other papillomaviruses (e.g., HPV16), a candidate vaccine against BPV1
consisting of L1 VLPs produced in planta elicited a strong and specific immune response, which
demonstrated its potential as a future vaccine that could be produced at a lower cost [84].
Because the viral life cycle and the progression from benign to malignant lesion are similar in
humans and animals, animal PVs and their natural hosts have represented good models for
the study of HPV [30,85]. In addition, animal PVs, particularly BPV1 and 4, SfPV1, and CPV1,
have also served as models for vaccines against PVs, and observation of the induction of
protective immunity through the use of VLP-based vaccines in their corresponding host
species has opened the way for the implementation of VLPs in HPV vaccines [86,87].
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Currently, immunization through the use of L2 protein peptides has been suggested as an
alternative to the use of VLP-based HPV vaccines. Curiously, residues at the N terminus of
the L2 viral protein appear to represent a cross-neutralizing epitope capable of eliciting a
broad-spectrum protection against many different viral types [87]. Once more, vaccination of
both cattle and rabbits with L2-based vaccines has been highly protective against challenge
with infectious virus [88,89], which confirms the great potential of L2 vaccines in preventing
HPV infections.
10. Conclusion
BPV infection is associated with cutaneous papillomatosis, enzootic hematuria and upper
gastrointestinal tract cancers in cattle. Although approximately 150 HPV types have already
been characterized, only 13 BPV types had their genomes sequenced. However, in accordance
with diversity observed from HPVs, the identification of numerous putative new BPV types
through partial L1 gene sequences have pointed to the occurrence of a similar diversity among
BPVs. Historically, together with a few animal PVs, BPVs and cattle have represented good
models for the study of HPV and vaccines against this important human pathogen, fact that
opened the way for the implementation of VLPs in HPV vaccines. The demonstration of
protective effect of L2-based vaccines in this animal species reinforces the possibility of the
future use of L2 protein peptides as an alternative vaccine to prevent HPV infections.
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